This FDA Decision That Could Decide When Cheaper Retatrutide Gets Approved (Retatrutide News)
Dr. Jones, DC — This FDA Decision That Could Decide When Cheaper Retatrutide Gets Approved (Retatrutide News)
Channel: Dr. Jones, DC · Our label: Chiropractor / clinician creator · Source: youtube.com/watch?v=DIfWqzQhCec
What this video covers
got some big news when it comes to Redat True Tide. So the FDA just made a call on Redat True Tide that could decide how long it’s going to be before anybody gets a cheaper version approved. So according to the decision reported literally this week, maybe two weeks by the time you’re watching this, the agency concluded for the second time that Reddit True Tide is a regular drug. That’s another setback for Eli Liy, which has been fighting this in federal court since 2024.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- So the FDA just made a call on Redat True Tide that could decide how long it’s going to be before anybody gets a cheaper version approved.
- The company asked the FDA to classify Reddit Shutai as a biologic.
- According to reporting on the FDA’s October 2nd decision, the FDA took its second try and it reached the same answer.
- According to that same reporting, the law gives the FDA 60 days to answer a request just like this.
- Then there’s the compounding, the rules that compoundingies work under, they cover drugs, but they don’t cover biologics.
- The FDA’s lawyers say their company has to challenge the FDA’s new decision in the lower court first.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.